Bausch Lomb

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) gained more than 3.5 percent early Thursday morning after the company announced the sale of one of its business units. Valeant has agreed to sell its iNova Pharmaceuticals business for $930 million to a group advised and managed by major...